Raybow Pharmaceutical announces $15.8 million expansion of U.S. site, tripling capacity and U.S. workforce

Raybow Pharmaceutical announces $15.8 million expansion of U.S. site, tripling capacity and U.S. workforce Image

FOR IMMEDIATE RELEASE
March 22, 2021

Brevard, N.C. – Raybow USA Inc, the North American unit of a global provider of outsourced pharmaceutical process development and manufacturing services, will expand its operations in North Carolina, tripling both its capacity and workforce. The company plans to add 74 jobs over the coming five years and will invest $15,800,000 at the Brevard facility.

Raybow USA was founded as PharmAgra Labs in 1999 by two North Carolina entrepreneurs. Today, the Brevard-based company is the North American unit of China’s Raybow Pharmaceuticals, a publicly-held contract development and manufacturing organization (CDMO) that partners with leading pharmaceutical companies across Asia, Europe and North America. The company has made sustainability and green chemistry central to its mission.

Raybow USA, which currently employs 24 in Brevard, focuses on early-stage R&D and process research through Phase II clinical trials.

Peter Halkjaer-Knudsen, Executive Vice President of Raybow Pharmaceuticals said, “Raybow Pharmaceuticals is proud to announce that, a year since we acquired the Brevard site, we are ready to further increase our commitment in North Carolina. We are grateful for the warm welcome we have received and the continued support we experienced during the feasibility studies for this expansion. Transylvania County has proven to be the right choice for our North American headquarters and R&D operations and we very much look forward to the continued journey with the people of North Carolina.”

Peter Newsome, Co-President of Raybow USA said, “These investments fit perfectly with our long-term goal of expanding our operations to meet the United States.” Roger Frisbee, Co-President of Raybow USA added, “We are excited about expanding our operations in Brevard and supporting future economic development in Transylvania County. Pete and I look forward to continuing our work, which now includes increased global capabilities and reach.”

New positions at Raybow USA will include research chemists, pilot-plant personnel and supervisors. Once the expansion is complete, the local region will benefit from a nearly $5.7 million payroll impact in the community, each and every year.

“North Carolina pioneered contract pharmaceutical discovery more than a generation ago, and today the industry connects many of our communities with global life sciences opportunities,” said Commerce Secretary Machelle Sanders. “We welcome this major expansion by Raybow USA, whose local roots showcase the best traditions of entrepreneurship in our state.

###

Other Raybow News & Papers

Raybow Pharmaceutical announces $15.8 million expansion of U.S. site, tripling capacity and U.S. workforce

Raybow Pharmaceutical announces $15.8 million expansion of U.S. site, tripling capacity and U.S. workforce

Raybow Attends Bio-Europe Digital - Oct. 26th thru 29th, 2020

BIO-Europe® Digital 2020, the largest life science partnering event in Europe, runs October 26th-29th. This event is being held digitally and Raybow is there!

Green Chemistry in the development and manufacturing of pharmaceuticals

First of all, Green Chemistry is “the development of chemical products and processes to reduce or eliminate the use and generation of hazardous substances” and “is intended to apply to the development and full lifecycle of a chemical product” i.e. development, manufacturing, application and disposal.

Back on-line after unexpected 18 day shut down due to Covid-19

Raybow is happy to announce that on Monday March 2nd we restored our Chinese R&D and manufacturing sites to full capacity.

Raybow Expands CDMO Business to U.S. with Acquisition of PharmAgra Labs

Raybow Pharmaceutical, a global pharmaceutical chemistry services provider, has acquired US-based PharmAgra Labs.